Kopran Ltd (KOPRAN) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 568367,
    "name": "Kopran",
    "stock_name": "Kopran",
    "full_name": "Kopran Ltd",
    "name_url": "stocks-analysis/kopran",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "133.85",
    "chg": 10.75,
    "chgp": "8.73%",
    "dir": 1,
    "prev_price": "123.10",
    "mcapval": "623.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524280,
    "symbol": "KOPRAN",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE082A01010",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "5.35 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/kopran-568367-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Kopran’s Evaluation Revised Amidst Challenging Financial and Technical Trends",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kopran-downgraded-to-strong-sell-by-marketsmojo-amid-weak-financials-and-bearish-technicals-3746328",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/Kopran_mojoScore_3746328.png",
        "date": "2025-12-04 11:08:46",
        "description": "Kopran, a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market assessment reflecting ongoing challenges in its financial performance and technical outlook. This adjustment follows a series of results that have highlighted persistent operational difficulties and subdued investor interest."
      },
      {
        "title": "Kopran Stock Falls to 52-Week Low of Rs.126.6 Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kopran-stock-falls-to-52-week-low-of-rs1266-amid-continued-weak-performance-3724752",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/Kopran_priceRelatedfactors_3724752.png",
        "date": "2025-11-24 10:42:33",
        "description": "Kopran, a company in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low price of Rs.126.6, marking a significant decline amid ongoing downward momentum. The stock has underperformed its sector and broader market indices, reflecting persistent challenges in its financial performance over recent quarters."
      },
      {
        "title": "Kopran Stock Falls to 52-Week Low of Rs.126.6 Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kopran-stock-falls-to-52-week-low-of-rs1266-amid-continued-weak-performance-3724749",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/Kopran_priceRelatedfactors_3724749.png",
        "date": "2025-11-24 10:42:30",
        "description": "Kopran, a player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.126.6, marking a significant decline in its stock price amid ongoing downward momentum and underperformance relative to its sector and broader market indices."
      },
      {
        "title": "Kopran Stock Falls to 52-Week Low of Rs.126.6 Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kopran-stock-falls-to-52-week-low-of-rs1266-amid-continued-weak-performance-3724763",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/Kopran_priceRelatedfactors_3724763.png",
        "date": "2025-11-24 10:42:23",
        "description": "Kopran, a player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.126.6 today, marking a significant milestone in its ongoing decline. The stock has underperformed its sector and broader market indices, reflecting persistent challenges in its financial performance and market positioning."
      },
      {
        "title": "Kopran Stock Falls to 52-Week Low of Rs.126.6 Amid Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kopran-stock-falls-to-52-week-low-of-rs1266-amid-continued-weak-performance-3724750",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/Kopran_priceRelatedfactors_3724750.png",
        "date": "2025-11-24 10:42:23",
        "description": "Kopran, a player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.126.6, marking a significant decline in its stock price amid ongoing downward momentum and underperformance relative to its sector and broader market indices."
      },
      {
        "title": "Kopran Stock Falls to 52-Week Low of Rs.126.6 Amid Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kopran-stock-falls-to-52-week-low-of-rs1266-amid-continued-weak-performance-3724748",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/Kopran_priceRelatedfactors_3724748.png",
        "date": "2025-11-24 10:42:21",
        "description": "Kopran, a player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.126.6, marking a significant decline amid ongoing downward momentum. The stock has underperformed its sector and broader market indices, reflecting persistent challenges in its financial performance over recent quarters."
      },
      {
        "title": "Kopran Stock Falls to 52-Week Low of Rs.126.6 Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kopran-stock-falls-to-52-week-low-of-rs1266-amid-continued-weak-performance-3724746",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/Kopran_priceRelatedfactors_3724746.png",
        "date": "2025-11-24 10:42:16",
        "description": "Kopran, a player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.126.6, marking a significant decline in its stock price amid ongoing downward momentum. This development comes despite a broadly positive market environment, with the Sensex trading near its 52-week high."
      },
      {
        "title": "Why is Kopran falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-kopran-fallingrising-3722137",
        "imagepath": "",
        "date": "2025-11-22 01:08:12",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Persistent Downtrend Against Market Benchmarks</strong></p>\n<p>Kopran’s recent price action reflects a sustained decline that has persisted over multiple time horizons. Over the past week, the stock has lost 9.45%, while the Sensex benchmark index has gained 0.79%. This divergence is even more pronounced over the last month, with Kopran falling 23.90% compared to the Sensex’s modest 0.95% rise. Year-to-date figures reveal a stark contrast: Kopran is down 39.73%, whereas the Sensex has advanced 9.08%. Over the last year, the stock has declined 35.41%, while the Sensex has appreciated 10.47%. Even on a three-year basis, Kopran’s performance lags significantly, with a 4.97% loss versus the Sensex’s 39.39% gain. Although the five-year return shows a modest 8.91% increase for Kopran, it pales in ..."
      },
      {
        "title": "Kopran Stock Falls to 52-Week Low of Rs.129 Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kopran-stock-falls-to-52-week-low-of-rs129-amid-continued-earnings-pressure-3720782",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/Kopran_priceRelatedfactors_3720782.png",
        "date": "2025-11-21 11:22:51",
        "description": "Kopran, a company operating in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.129, marking a significant decline in its stock price. This drop reflects ongoing challenges in the company’s financial performance and market positioning, with the stock trading below all major moving averages and underperforming its sector peers."
      }
    ],
    "total": 251,
    "sid": "568367",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/kopran-568367"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
      "datetime": "23-Jan-2026",
      "details": "Investor Presentation for Q3 FY 2025-26",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "23-Jan-2026",
      "details": "Newspaper Advertisement for the Q3 Results FY 2025-26",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Results For Q3 FY 2025-26",
      "datetime": "22-Jan-2026",
      "details": "Unaudited Results for standalone and consolidated for Q3 FY 2025-26",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Kopran Ltd has declared <strong>30%</strong> dividend, ex-date: 04 Sep 25",
          "dt": "2025-09-04",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Kopran’s Evaluation Revised Amidst Challenging Financial and Technical Trends

2025-12-04 11:08:46

Kopran, a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market assessment reflecting ongoing challenges in its financial performance and technical outlook. This adjustment follows a series of results that have highlighted persistent operational difficulties and subdued investor interest.

Kopran Stock Falls to 52-Week Low of Rs.126.6 Amidst Continued Downtrend

2025-11-24 10:42:33

Kopran, a company in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low price of Rs.126.6, marking a significant decline amid ongoing downward momentum. The stock has underperformed its sector and broader market indices, reflecting persistent challenges in its financial performance over recent quarters.

Kopran Stock Falls to 52-Week Low of Rs.126.6 Amidst Continued Downtrend

2025-11-24 10:42:30

Kopran, a player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.126.6, marking a significant decline in its stock price amid ongoing downward momentum and underperformance relative to its sector and broader market indices.

Kopran Stock Falls to 52-Week Low of Rs.126.6 Amidst Continued Downtrend

2025-11-24 10:42:23

Kopran, a player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.126.6 today, marking a significant milestone in its ongoing decline. The stock has underperformed its sector and broader market indices, reflecting persistent challenges in its financial performance and market positioning.

Kopran Stock Falls to 52-Week Low of Rs.126.6 Amid Continued Downtrend

2025-11-24 10:42:23

Kopran Stock Falls to 52-Week Low of Rs.126.6 Amid Continued Downtrend

2025-11-24 10:42:21

Kopran, a player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.126.6, marking a significant decline amid ongoing downward momentum. The stock has underperformed its sector and broader market indices, reflecting persistent challenges in its financial performance over recent quarters.

Kopran Stock Falls to 52-Week Low of Rs.126.6 Amidst Continued Downtrend

2025-11-24 10:42:16

Kopran, a player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.126.6, marking a significant decline in its stock price amid ongoing downward momentum. This development comes despite a broadly positive market environment, with the Sensex trading near its 52-week high.

Why is Kopran falling/rising?

2025-11-22 01:08:12

Persistent Downtrend Against Market Benchmarks Kopran’s recent price action reflects a sustained decline that has persisted over multiple time horizons. Over the past week, the stock has lost 9.45%, while the Sensex benchmark index has gained 0.79%. This divergence is even more pronounced over the last month, with Kopran falling 23.90% compared to the Sensex’s modest 0.95% rise. Year-to-date figures reveal a stark contrast: Kopran is down 39.73%, whereas the Sensex has advanced 9.08%. Over the last year, the stock has declined 35.41%, while the Sensex has appreciated 10.47%. Even on a three-year basis, Kopran’s performance lags significantly, with a 4.97% loss versus the Sensex’s 39.39% gain. Although the five-year return shows a modest 8.91% increase for Kopran, it pales in ...

Kopran Stock Falls to 52-Week Low of Rs.129 Amidst Continued Downtrend

2025-11-21 11:22:51

Kopran, a company operating in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.129, marking a significant decline in its stock price. This drop reflects ongoing challenges in the company’s financial performance and market positioning, with the stock trading below all major moving averages and underperforming its sector peers.

View All News